Patents by Inventor Kevin Wayne Meyer

Kevin Wayne Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single reactor for simplified sample preparation workflows
    Patent number: 10551358
    Abstract: This disclosure provides a single reactor that accommodates an affinity selector to separate analytes of interest, and an enzyme reactor that digest the analyte to suitable peptides for mass spectrometry. The single reactor formats described herein accommodate workflows wherein separation precedes digestion as well as workflows wherein digestion precedes separation selection.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 4, 2020
    Assignee: Perfinity Bioscices, Inc.
    Inventors: Kevin Wayne Meyer, John Patrick O'Grady, Bob Harold Ellis, Derrick Nathaniel Poe, Nicholas Brian Herold
  • Robust, easy to use immobilized enzyme reactors
    Patent number: 10266819
    Abstract: The disclosure provides an innovative immobilized enzyme reactor working system that includes improved reactor formats, heating element, optimum buffers, filtration apparatus and collection componentry for easy to use sample preparation. The system provides enhanced recovery, improved reproducibility and parallel processing capabilities capable of quantitatively processing hundreds of difficult to digest samples simultaneously in a shortened period of time.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: April 23, 2019
    Assignee: PERFINITY BIOSCIENCES, INC.
    Inventors: Kevin Wayne Meyer, John Patrick O'Grady, Robert Harold Ellis, Nicholas Brian Herold, Derrick Nathaniel Poe
  • A SINGLE REACTOR FOR SIMPLIFIED SAMPLE PREPARATION WORKFLOWS
    Publication number: 20160341704
    Abstract: This disclosure provides a single reactor that accommodates an affinity selector to separate analytes of interest, and an enzyme reactor that digest the analyte to suitable peptides for mass spectrometry. The single reactor formats described herein accommodate workflows wherein separation precedes digestion as well as workflows wherein digestion precedes separation selection.
    Type: Application
    Filed: December 1, 2014
    Publication date: November 24, 2016
    Inventors: Kevin Wayne MEYER, John Patrick O'GRADY, Bob Harold ELLIS, Derrick Nathaniel POE, Nicholas Brian HEROLD
  • ROBUST, EASY TO USE IMMOBILIZED ENZYME REACTORS
    Publication number: 20150361415
    Abstract: The disclosure provides an innovative immobilized enzyme reactor working system that includes improved reactor formats, heating element, optimum buffers, filtration apparatus and collection componentry for easy to use sample preparation. The system provides enhanced recovery, improved reproducibility and parallel processing capabilities capable of quantitatively processing hundreds of difficult to digest samples simultaneously in a shortened period of time.
    Type: Application
    Filed: January 30, 2014
    Publication date: December 17, 2015
    Applicant: Perfinity Biosciences, Inc.
    Inventors: Kevin Wayne MEYER, John Patrick O'GRADY, Robert Harold ELLIS, NICHOLAS Brian HEROLD, Derrick Nathaniel POE
  • Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol
    Patent number: 8975410
    Abstract: This invention relates to novel polymorphs of (HO)2NO2(C6H)—(C2N2O)—(C5N)(CH3)2Cl2O, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: March 10, 2015
    Assignee: BIAL—Portela & CA., S.A.
    Inventors: David Alexander Learmonth, Keith Lorimer, Kevin Wayne Meyer, Tibor Eszenyi, Álmosné Kovách
  • CRYSTAL FORMS OF 5-[3-(2,5-DICHLORO-4, 6-DIMETHYL-1-OXY-PYRIDINE-3-YL)[1,2,4] OXADIAZOL-5-YL]-3-NITROBENZENE-1,2-DIOL
    Publication number: 20110112301
    Abstract: This invention relates to novel polymorphs of (HO)2NO2(C6H)—(C2N2O)—(C5N)(CH3)2Cl2O, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.
    Type: Application
    Filed: March 16, 2009
    Publication date: May 12, 2011
    Applicant: BIAL - PORTELA & CA., S.A.
    Inventors: David Alexander Learmonth, Keith Lorimer, Kevin Wayne Meyer, Tibor Eszenyi, Álmosné Kovách
  • AMORPHOUS METAXALONE AND AMORPHOUS DISPERSIONS THEREOF
    Publication number: 20090163561
    Abstract: The present invention provides various amorphous forms of the compound metaxalone (I), such as solid amorphous metaxalone and amorphous dispersions comprising metaxalone. The present invention further provides pharmaceutical compositions comprising these amorphous forms, and methods of their preparation. The present invention additionally provides methods of treating painful conditions (e.g., such as painful musculoskeletal conditions) comprising administering a therapeutically effective amount of any one of these amorphous forms to a subject in need thereof.
    Type: Application
    Filed: December 11, 2008
    Publication date: June 25, 2009
    Applicant: URL Pharma, Inc.
    Inventors: Keith Lorimer, Kevin Wayne Meyer, Tong Sun, Shawn Watson, Kurt R. Nielsen
  • Quinine Sulfate Polymorphs, Processes of Preparing, Compositions and Uses Thereof
    Publication number: 20090163540
    Abstract: Disclosed are new quinine sulfate polymorphs, methods of making the polymorphs as well as formulations prepared therefrom and uses thereof.
    Type: Application
    Filed: December 17, 2008
    Publication date: June 25, 2009
    Inventors: Tong Sun, Keith Lorimer, Kevin Wayne Meyer, Kurt R. Nielsen, Shawn Watson